Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QHU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,011
Award facts
- Contract value 100% obligated
- $19,011.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,011.34 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml packaging. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal medical supply chain, particularly for military and veteran healthcare systems. The company's SPE2DX prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. This specific delivery order for Cosentyx, an immunosuppressant medication used to treat conditions such as psoriasis and rheumatoid arthritis, exemplifies the company's role in supporting the Defense Health Agency's pharmaceutical procurement needs through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F3QHU?
SPE2DR26F3QHU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F3QHU worth?
The government has obligated $19,011 on SPE2DR26F3QHU.
Is contract SPE2DR26F3QHU an order under another contract?
Yes. SPE2DR26F3QHU is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QHU competed?
The extent of competition for SPE2DR26F3QHU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award